Background: Hypoglycemia is a serious complication following the administration of insulin for hyperkalemia. We determined the incidence of hypoglycemia and severe hypoglycemia (blood glucose <70 or ≤40 mg/dl, respectively) in a cohort of AKI and non-dialysis dependent CKD patients who received an intravenous infusion of insulin plus glucose to treat hyperkalemia. Methods: We retrospectively reviewed charts of all AKI and non-dialysis dependent CKD patients who received 10 U of insulin plus 50 g glucose to treat hyperkalemia from December 1, 2013 to May 31, 2015 at our Department. Results: One hundred sixty four episodes of hyperkalemia were treated with insulin plus glucose and were eligible for analysis. Serum pota...
Objectives: Insulin administration lowers plasma potassium concentration by augmenting intracellular...
Objectives: Insulin administration lowers plasma potassium concentration by augmenting intracellular...
Objectives: Insulin administration lowers plasma potassium concentration by augmenting intracellular...
Background: Hypoglycemia is a serious complication following the administration of insulin for hyper...
Background: Hypoglycemia is a serious complication following the administration of insulin for hyper...
BACKGROUND:Hypoglycemia is a serious complication following the administration of insulin for hyperk...
Hypoglycemia is a serious complication following the administration of insulin for hyperkalemia. We ...
Producción CientíficaBackground: Hypoglycemia is a serious complication following the administration...
Study Objectives: This study’s objective was to determine key clinical predictors of hypoglycemia fo...
Introduction: Complications associated with insulin treatment for hyperkalemia are serious and commo...
Complications associated with insulin treatment for hyperkalemia are serious and common. We hypothes...
Introduction: Complications associated with insulin treatment for hyperkalemia are serious and commo...
Background and Objectives: Hypoglycemia is one of the most complications of treatment for hyperkalem...
Purpose: To compare the effects of weight-based, reduced, and standard IV insulin doses on potassium...
ESRD patients are vulnerable to hypoglycemia due to impaired insulin clearance, glucose metabolism c...
Objectives: Insulin administration lowers plasma potassium concentration by augmenting intracellular...
Objectives: Insulin administration lowers plasma potassium concentration by augmenting intracellular...
Objectives: Insulin administration lowers plasma potassium concentration by augmenting intracellular...
Background: Hypoglycemia is a serious complication following the administration of insulin for hyper...
Background: Hypoglycemia is a serious complication following the administration of insulin for hyper...
BACKGROUND:Hypoglycemia is a serious complication following the administration of insulin for hyperk...
Hypoglycemia is a serious complication following the administration of insulin for hyperkalemia. We ...
Producción CientíficaBackground: Hypoglycemia is a serious complication following the administration...
Study Objectives: This study’s objective was to determine key clinical predictors of hypoglycemia fo...
Introduction: Complications associated with insulin treatment for hyperkalemia are serious and commo...
Complications associated with insulin treatment for hyperkalemia are serious and common. We hypothes...
Introduction: Complications associated with insulin treatment for hyperkalemia are serious and commo...
Background and Objectives: Hypoglycemia is one of the most complications of treatment for hyperkalem...
Purpose: To compare the effects of weight-based, reduced, and standard IV insulin doses on potassium...
ESRD patients are vulnerable to hypoglycemia due to impaired insulin clearance, glucose metabolism c...
Objectives: Insulin administration lowers plasma potassium concentration by augmenting intracellular...
Objectives: Insulin administration lowers plasma potassium concentration by augmenting intracellular...
Objectives: Insulin administration lowers plasma potassium concentration by augmenting intracellular...